Three insiders purchased a total of 24,000 shares of Tabula Rasa HealthCare (TRHC, Financial), and one insider sold 4,070 shares on Oct. 4, according to the Securities and Exchange Commission.
Michael J. Gausling, 10% owner, purchased 8,000 shares, Eric R. Arnson,10% owner, purchased 7,500 shares, and Glen R. Bressner, director and 10% owner, purchased 8,500 shares. All of the purchases came at price of $12 per share. Joann M. Durham, 10% owner, sold 4,070 shares of the company’s stock on Oct. 4. Since the trades, Tabula Rasa HealthCare's market price has gained an estimated 12.08%.
Tabula Rasa HealthCare was incorporated in May 2014. The company is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company uses cloud-based software solutions to its prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to improve the medication related needs of its patients. In 2014, the company filled 4.3 billion prescriptions in the United States.
The company has a market cap of $202.45 million and approximately 15.51 million shares outstanding.
Tabula Rasa HealthCare has reported strong financial statements since December 2014, which is a good sign for investors despite a small sample size of data.
Tabula Rasa has nearly doubled its revenue from a reported $48.43 million in December 2014 to $80.29 million over the previous trailing twelve months. The company has also more than doubled its profits since December 2014 from $10.62 million to $24.04 million over the previous trailing twelve months. The company has also improved its EBITDA nearly 5-fold since December 2014 from a reported $1.66 million to $8.17 million over the previous trailing twelve months.
Tabula Rasa HealthCare went public on Sept. 29 at $12.00 per share. Since the company’s initial public offering, its market price has gained an estimated 12.08%.
Disclosure: Author does not own any shares of this company.
Start a free 7-day trial of Premium Membership to GuruFocus.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
